XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Initial Public Offering
Private Placement
Redeemable convertible preferred stock
Redeemable convertible preferred stock
Initial Public Offering
Series D-1 Redeemable Convertible Preferred Shares
Series E Redeemable Convertible Preferred Stock
Series E-2 Redeemable Convertible Preferred Stock
Common Stock
Common Stock
Initial Public Offering
Common Stock
Private Placement
Additional Paid-in Capital
Additional Paid-in Capital
Initial Public Offering
Additional Paid-in Capital
Private Placement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total TuSimple Holdings Inc. Stockholders’ Deficit
Noncontrolling Interests
Beginning Balance (in shares) at Dec. 31, 2019       74,939,388                            
Beginning Balance at Dec. 31, 2019       $ 293,736                            
Ending Balance (in shares) at Mar. 31, 2020       74,939,388                            
Ending Balance at Mar. 31, 2020       $ 293,736                            
Beginning Balance (in shares) at Dec. 31, 2019                 56,516,425                  
Beginning Balance at Dec. 31, 2019 $ (219,414)               $ 6     $ 0     $ (658) $ (218,718) $ (219,370) $ (44)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock from exercise of options (in shares)                 2,125,000                  
Stock-based compensation 1,227                     1,227         1,227  
Acquisition of noncontrolling interest in subsidiary                             (44)   (44) 44
Foreign currency translation adjustment 2                           2   2  
Net loss (25,761)                             (25,761) (25,761)  
Ending Balance (in shares) at Mar. 31, 2020                 58,641,425                  
Ending Balance at Mar. 31, 2020 (243,946)               $ 6     1,227     (700) (244,479) (243,946) 0
Beginning Balance (in shares) at Dec. 31, 2019       74,939,388                            
Beginning Balance at Dec. 31, 2019       $ 293,736                            
Ending Balance (in shares) at Sep. 30, 2020       76,788,483                            
Ending Balance at Sep. 30, 2020       $ 308,736                            
Beginning Balance (in shares) at Dec. 31, 2019                 56,516,425                  
Beginning Balance at Dec. 31, 2019 (219,414)               $ 6     0     (658) (218,718) (219,370) (44)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Foreign currency translation adjustment 475                                  
Ending Balance (in shares) at Sep. 30, 2020                 60,542,721                  
Ending Balance at Sep. 30, 2020 (364,854)               $ 6     0     (227) (364,633) (364,854) 0
Beginning Balance (in shares) at Mar. 31, 2020       74,939,388                            
Beginning Balance at Mar. 31, 2020       $ 293,736                            
Ending Balance (in shares) at Jun. 30, 2020       74,939,388                            
Ending Balance at Jun. 30, 2020       $ 293,736                            
Beginning Balance (in shares) at Mar. 31, 2020                 58,641,425                  
Beginning Balance at Mar. 31, 2020 (243,946)               $ 6     1,227     (700) (244,479) (243,946) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Stock-based compensation 453                     453         453  
Foreign currency translation adjustment 188                           188   188  
Net loss (28,084)                             (28,084) (28,084)  
Ending Balance (in shares) at Jun. 30, 2020                 58,641,425                  
Ending Balance at Jun. 30, 2020 (271,389)               $ 6     1,680     (512) (272,563) (271,389) 0
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)           1,849,095                        
Issuance of redeemable convertible preferred stock, net of issuance costs           $ 3,057                        
Accretion of redeemable convertible preferred stock to redemption value       $ 11,943                            
Ending Balance (in shares) at Sep. 30, 2020       76,788,483                            
Ending Balance at Sep. 30, 2020       $ 308,736                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of restricted ordinary shares (in shares)                 1,899,680                  
Issuance of common stock from exercise of options (in shares)                 1,616                  
Accretion of redeemable convertible preferred stock to redemption value (11,943)                     (9,325)       (2,618) (11,943)  
Stock-based compensation 7,645                     7,645         7,645  
Foreign currency translation adjustment 285                           285   285  
Net loss (89,452)                             (89,452) (89,452)  
Ending Balance (in shares) at Sep. 30, 2020                 60,542,721                  
Ending Balance at Sep. 30, 2020 $ (364,854)               $ 6     0     (227) (364,633) $ (364,854) $ 0
Beginning Balance (in shares) at Dec. 31, 2020 102,074,703     102,074,703                            
Beginning Balance at Dec. 31, 2020 $ 664,791     $ 664,791                            
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Issuance of redeemable convertible preferred stock, net of issuance costs (in shares)             4,650,999                      
Issuance of redeemable convertible preferred stock, net of issuance costs             $ 61,631                      
Issuance of redeemable convertible preferred stock from the exercise of warrants (in shares)             9,477,073 4,331,644                    
Issuance of redeemable convertible preferred stock from the exercise of warrants             $ 379,084 $ 173,275                    
Accretion of redeemable convertible preferred stock to redemption value       $ 4,135                            
Ending Balance (in shares) at Mar. 31, 2021       120,534,419                            
Ending Balance at Mar. 31, 2021       $ 1,282,916                            
Beginning Balance (in shares) at Dec. 31, 2020                 60,543,337                  
Beginning Balance at Dec. 31, 2020 (405,473)               $ 6     0     (301) (405,178)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock from exercise of options (in shares)                 60,616                  
Issuance of common stock from exercise of options 1                     1            
Vesting of early exercised stock options 21                     21            
Accretion of redeemable convertible preferred stock to redemption value (4,135)                     (4,135)            
Stock-based compensation 6,289                     6,289            
Foreign currency translation adjustment 911                           911      
Net loss (385,160)                             (385,160)    
Ending Balance (in shares) at Mar. 31, 2021                 60,603,953                  
Ending Balance at Mar. 31, 2021 $ (787,546)               $ 6     2,176     610 (790,338)    
Beginning Balance (in shares) at Dec. 31, 2020 102,074,703     102,074,703                            
Beginning Balance at Dec. 31, 2020 $ 664,791     $ 664,791                            
Ending Balance (in shares) at Sep. 30, 2021 0     0 0                          
Ending Balance at Sep. 30, 2021 $ 0     $ 0                            
Beginning Balance (in shares) at Dec. 31, 2020                 60,543,337                  
Beginning Balance at Dec. 31, 2020 (405,473)               $ 6     0     (301) (405,178)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Foreign currency translation adjustment 63                                  
Ending Balance (in shares) at Sep. 30, 2021                 212,994,830                  
Ending Balance at Sep. 30, 2021 1,410,039               $ 21     2,432,613     (238) (1,022,357)    
Beginning Balance (in shares) at Mar. 31, 2021       120,534,419                            
Beginning Balance at Mar. 31, 2021       $ 1,282,916                            
Increase (Decrease) in Temporary Equity [Roll Forward]                                    
Conversion of redeemable convertible preferred stock in connection with initial public offering (in shares)         (120,534,419)                          
Conversion of redeemable convertible preferred stock in connection with initial public offering         $ (1,282,916)                          
Ending Balance (in shares) at Jun. 30, 2021       0                            
Ending Balance at Jun. 30, 2021       $ 0                            
Beginning Balance (in shares) at Mar. 31, 2021                 60,603,953                  
Beginning Balance at Mar. 31, 2021 (787,546)               $ 6     2,176     610 (790,338)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Vesting of early exercised stock options 21                     21            
Conversion of convertible common stock in connection with initial public offering (in shares)                   120,534,419                
Conversion of convertible common stock in connection with initial public offering   $ 1,282,916               $ 12     $ 1,282,904          
Issuance of common stock (in shares)                   27,027,027 874,999              
Issuance of common stock   $ 1,027,374 $ 35,000             $ 3     $ 1,027,371 $ 35,000        
Stock-based compensation 52,509                     52,509            
Foreign currency translation adjustment (775)                           (775)      
Net loss (116,529)                             (116,529)    
Ending Balance (in shares) at Jun. 30, 2021                 209,040,398                  
Ending Balance at Jun. 30, 2021 $ 1,492,970               $ 21     2,399,981     (165) (906,867)    
Ending Balance (in shares) at Sep. 30, 2021 0     0 0                          
Ending Balance at Sep. 30, 2021 $ 0     $ 0                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Issuance of common stock from exercise of options (in shares)                 183,648                  
Issuance of common stock from exercise of options 529                     529            
Issuance of common stock related to release of RSU and SVAs (in shares)                 3,770,784                  
Vesting of early exercised stock options 21                     21            
Stock-based compensation 32,082                     32,082            
Foreign currency translation adjustment (73)                           (73)      
Net loss (115,490)                             (115,490)    
Ending Balance (in shares) at Sep. 30, 2021                 212,994,830                  
Ending Balance at Sep. 30, 2021 $ 1,410,039               $ 21     $ 2,432,613     $ (238) $ (1,022,357)